𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫

Telling the Story of Theranostics in Oncology

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

⚛️ Multiplexed imaging of radionuclides

📌 𝘕𝘢𝘵𝘶𝘳𝘦 𝘉𝘪𝘰𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘌𝘯𝘨𝘪𝘯𝘦𝘦𝘳𝘪𝘯𝘨
📖 https://t.co/yYAwF3Bmwd
👥 George Soultanidis, et al.

#MultiplexedImaging #RadionuclideImaging #MolecularImaging #Theranostics #NuclearMedicine

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

Retreatment with ²²³Ra is both safe and effective in patients with bone-metastatic metastatic castration-resistant prostate cancer.

@JournalofNucMed
https://t.co/RWCGk9CvFg

#Radium223 #mCRPC #ProstateCancer

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

📈 [𝟭𝟴𝗙]𝗙𝗗𝗚 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗧𝘂𝗺𝗼𝗿 𝗩𝗼𝗹𝘂𝗺𝗲 𝗮𝘀 𝗮 𝗣𝗿𝗼𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗠𝗮𝗿𝗸𝗲𝗿 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗲𝗻𝗱𝗼𝗰𝗿𝗶𝗻𝗲 𝗡𝗲𝗼𝗽𝗹𝗮𝘀𝗺: 𝗔 𝗠𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝗦𝘁𝘂𝗱𝘆

📖https://t.co/U1bElcna1v

@JournalofNucMed
#OncTheraX #NeuroendocrineTumors #NEN

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

♻️ Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions

📘 https://t.co/PcV7W3ZhCM

#OncTheraX #TargetedAlphaTherapy #TAT #AlphaEmitters #Theranostics

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧪 Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

📄 Journal of Clinical Oncology
📖 Read here: https://t.co/RhbuhB1dzP

#Neuroblastoma

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🔬 Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

https://t.co/4t0cRJGaiE

#OncTheraX #MolecularImaging #PrecisionMedicine #Theranostics

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧬 NIH Clinical Center (CC): Providing hope through pioneering clinical research that transforms and improves human health.

@NIH
#NIHClinicalCenter #HumanHealth #Theranostics

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🎯 𝗖𝗮𝗹𝗹 𝗳𝗼𝗿 𝗔𝗯𝘀𝘁𝗿𝗮𝗰𝘁𝘀– 𝟭𝟮𝗜𝗖𝗜 𝗙𝗹𝗼𝗿𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟲 🧪🌍

📍 Location: Palazzo dei Congressi, Florence, Italy
🗓️ Date: 15–19 February 2026

Deadline: 30 September 2025, 23:59 CET
https://t.co/eUy4qUmcRQ

#12ICI

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

In patients with high-volume metastatic #ProstateCancer who still had disease after initial treatment, ¹⁷⁷Lu-PSMA-617 consolidation therapy demonstrated promising efficacy and safety outcomes.

📚 The Journal of Nuclear Medicine - JNM, July 2025
🔗 https://t.co/pWi1YOzEMk

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧠 Multimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy

📘 𝘕𝘢𝘯𝘰𝘴𝘤𝘢𝘭𝘦, 2025
🔗https://t.co/Jdu2tQMnsz

#Theranostics #Glioblastoma #Nanomedicine #MRI #IntravitalMicroscopy

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

📚 Essentials of Theranostics: A Guide for Physicians and Medical Physicists

📘 𝘙𝘢𝘥𝘪𝘰𝘎𝘳𝘢𝘱𝘩𝘪𝘤𝘴
🔗https://t.co/Q7kWIL7P14

#Theranostics #NuclearMedicine

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧬 Not All BRAF V600E Mutations Are Equal: The Impact of Allele Frequency

✍️Eyal Robenshtok M.D.
📘 Clinical Thyroidology
Tumors with high BRAF V600E AF were associated with more gross ETE and increased recurrence risk.

🔗https://t.co/CJ59rklzX6

#ClinicalThyroidology

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🔬📖 Theranostics as an Emerging Integrated Imaging and Therapies in Precision Oncology

📚 𝘕𝘢𝘯𝘰𝘵𝘩𝘦𝘳𝘢𝘯𝘰𝘴𝘵𝘪𝘤𝘴 𝘧𝘰𝘳 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴 𝘢𝘯𝘥 𝘛𝘩𝘦𝘳𝘢𝘱𝘺
🖋️ Dr. Mohamad Taleuzzaman et al.

🔗 Read the chapter: https://t.co/OO2IveHhr9

#Theranostics

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧬 Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

📚 𝘕𝘢𝘵𝘶𝘳𝘦 𝘊𝘰𝘮𝘮𝘶𝘯𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴
🔗 Read the full article: https://t.co/Uk3HWTISZh

#Theranostics #mTOR #PhotodynamicTherapy #Immunotherapy

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🔬 The Diagnostic Accuracy of 18F-FDG PET and 18F-FES PET for Staging Grade 1–2 Estrogen Receptor–Positive Breast Cancer

🔗Read the article: https://t.co/Y5HLti1OmR

📚 𝘙𝘢𝘥𝘪𝘰𝘭𝘰𝘨𝘺 (𝘙𝘚𝘕𝘈)
📝 Jelijn Knip et al

#Radiology #NuclearMedicine #FDGPET #FESPET #BreastCancer

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧠 Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis

🔗 Read the article: https://t.co/H2jtXHIlsE
@EnteOspedaliero (EOC)

#NuclearMedicine #Theranostics #PRRT #NeuroOncology

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🧬 Carcinoid heart disease: how to manage it. A practical guide for the clinician

📚 By Daniela Cardinale & Chiara Maria Grana
🗞️ 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘛𝘳𝘢𝘯𝘴𝘭𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘐𝘮𝘢𝘨𝘪𝘯𝘨
🔗 Read the article: https://t.co/XzQ7hRyFBO

#Cardiology #NeuroendocrineTumors

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

📊 Rethinking Dosimetry: A European Perspective

@JournalofNucMed

🔗 Read the full paper: https://t.co/DZU5kYvIfR

#Dosimetry #NuclearMedicine

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

🎯 Augerlicious: Terbium-161 Double Punch to Cancer Cells

🎥 Live & Free Webinar
📅 September 17, 2025 — 🕚 11:30 PM
🔗 Register: https://t.co/fz1MIt6zQY

@DrMHofman

#ProstateCancer #Terbium161 #Theranostics #NuclearMedicine #Webinar #Oncology

[𝗢𝗻𝗰𝗧𝗵𝗲𝗿𝗮𝗫 @OncTheraX]

📄 Theranostics in Perspective: White Paper

👨‍🔬 By Marcel Stokkel, Martin Gotthardt, Ken Herrmann, and Gopinath Gnanasegaran

🗞️ Published in @JournalofNucMed , July 2025
🔗https://t.co/Y3jQJudDqw

#Theranostics #NuclearMedicine #Radiotheranostics #TargetedTherapy